Issuer Free Writing Prospectus, dated September 7, 2010
Filed Pursuant to Rule 433
Relating to the Preliminary Prospectus Supplement
dated September 7, 2010 and
Registration Statement No. 333-159040
Health Care REIT, Inc.
Pricing Term Sheet
$450,000,000 4.70% Notes due 2017
| |
|
|
|
Issuer:
|
|
Health Care REIT, Inc. |
|
|
|
Size:
|
|
$450,000,000 |
|
|
|
Maturity:
|
|
September 15, 2017 |
|
|
|
Coupon (Interest Rate):
|
|
4.70% |
|
|
|
Yield to Maturity:
|
|
4.749% |
|
|
|
Spread to Benchmark Treasury:
|
|
T+270 bps |
|
|
|
Benchmark Treasury:
|
|
1.875% due August 31, 2017 |
|
|
|
Benchmark Treasury Price and Yield:
|
|
98-28 / 2.049% |
|
|
|
Interest Payment Dates:
|
|
March 15 and September 15, commencing
March 15, 2011 |
|
|
|
Redemption Provision:
|
|
T+40 bps |
|
|
|
Price to Public:
|
|
99.710% |
|
|
|
Settlement Date:
|
|
T+3; September 10, 2010 |
|
|
|
CUSIP / ISIN:
|
|
42217K AT3 / US42217KAT34 |
|
|
|
Ratings*:
|
|
Baa2 by Moody’s Investors Service,
Inc. / BBB- by Standard & Poor’s
Ratings Services / BBB by Fitch
Ratings Ltd. |
|
|
|
Joint Book-Running Managers:
|
|
UBS Securities LLC, J.P. Morgan
Securities LLC, Barclays Capital Inc. |
|
|
|
Co-Managers:
|
|
RBS Securities Inc., PNC Capital
Markets LLC, Comerica
Securities, Inc., Fifth Third
Securities, Inc. |
*Note: A securities rating is not a recommendation to buy, sell or hold securities and may be
subject to revision or withdrawal at any time.
The issuer has filed a registration statement (including a base prospectus) and a related
preliminary prospectus supplement dated September 7, 2010 with the SEC for the offering to which
this communication relates. Before you invest, you should read the base prospectus in that
registration statement, the related preliminary prospectus supplement and the other documents the
issuer has filed with the SEC for more complete information about the issuer and this offering.
You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov.
Alternatively, UBS Securities LLC can arrange to send you the prospectus if you request it by
calling UBS Securities LLC toll free at (877) 827-6444, extension 561-3884.